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CLOSE-UP REPORT
ANIMALS
ARE
SUFFERING
HSUS seeks to end
rabbit blinding tests

Annually, 65 to 100 million animals are being used as test
subjects in the laboratories of cosmetic companies, drug manu
facturers, university and commercial research centers, and pro
ducers of household products. The Humane Society of the
United States has taken the position that much of this test
ing is not only unreliable, but also results in unnecessary pain
and death.
Cats, dogs, birds, rats, mice, monkeys, and rabbits are
just some of the animals routinely subjected to electric
shocks, rubber riot control bullets, huge doses of
radiation, and chemical solutions.
The research industry has long held that the
use of animals is the only "reliable" way we have
of determining the safety of a cosmetic, drug, or
household product. Over the years this belief has
served to support scientists as they subjected animals to many tests. The American public has seen
little of the massive animal suffering that has
taken place in the research labs.
Today, a new debate is taking
place. People from all walks of life
are asking if all the suffering and
death is worth it. Many research
scientists have joined the ranks of
those who are questioning the sci
entific and ethical foundation of
using animals for research sub
jects. Scientists have developed
new techniques utilizing tissue cul
tures, computer models, and bacteria
which can be used to test the safety of
substances.
One of the most outrageous tests currently
being used is the Draize test to determine the eye
irritancy of substances. Drops of soap, perfume,
and other common products are put into the eyes of
albino rabbits to find out if these things are harmful
to human eyes. Because of the pain and suffering which
are created by the Draize test which is unreliable, The
HSUS has formally asked government regulatory
agencies to find alternatives to the test. "Some knowl
edge can be obtained at too high a price," says phys
iologist Dr. D.H. Smyth in his book, Alternatives to
Animal Experiments.
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What is the Draize Test?

More than 35 years ago, Dr. J.H. Draize and
several of his colleagues at the Food and Drug Ad
ministration (FDA) developed a test to assess the eye
irritancy of chemicals and mixtures of chemicals.
This Draize test is now routinely used on albino rab
bits to test cosmetics, toiletries, pesticides, drugs, and
other chemicals before they are put on the market.
The Draize test involves, or can involve, a great
deal of pain. It provides crude information on
whether or not a substance will irritate human eyes.
Because of the animal suffering involved and the
poor quality of the information obtained, The
Humane Society of the United States along with a
coalition of more than 300 local animal welfare
groups has asked FDA, other agencies, and the
cosmetic industry to devote time and money to the
development of an alternative to the Draize test
which does not involve the use of animals.
Federal regulations specify that albino rabbits
must be used in eye irritancy studies. The rabbits'
eyes are by no means ideal substitutes for human
eyes. The corneas of rabbits' eyes are thinner than
human corneas and rabbits have far less efficient tear
glands. Although the nictitating membrane in rabbits'
eyes may compensate for the lack of the cleansing ef
fect of tears, this is by no means certain.
Six to nine rabbits are used for each test. One eye
of each rabbit is left untreated to serve as a control,
while the test substance is forced into the other eye.
The rabbits may or may not be restrained in stocks,
as shown in the photo. Observations are made 1, 24,
48, 72, and 168 hours after treatment. The substance
is then scored on a scale ranging from O to 110
developed by Draize and his colleagues which relies
on the following features:
(a) the development of opaqueness in the cornea,
(b) inflammation in the iris,
(c) inflammation of the conjunctivae.
The total score is meant to give some measure of the
irritancy potential of the test substance.
Twenty-seven years after the Draize test had been
developed, two American toxicologists conducted a
major survey of its reliability. They distributed
twelve compounds to twenty-four government and
industrial laboratories, including Avon, Colgate
Palmolive, General Foods, American Cyanamid and
the Food and Drug Directorate in Canada. Each was
to follow a set procedure in assessing the eye irritancy
of each compound. The Draize test was found to be
unreliable.
Three of the substances were so mild that no
laboratory reported them as irritants. However, there
was wide variation on each of the remaining nine
substances. For example, after 24 hours, one labora
tory reported a median score of 7 for ethoxylated
lauryl alcohol while another gave it a 79. These were

Rabbit being held to show eyeball and conjunctiva!
sac into which sample for testing is placed.
the extreme scores from the twenty-four different
laboratories; but it means that one would report the
alcohol as being highly irritant, while another would
report it as being a non-irritant. It is hardly surprising
that, when the report appeared in 1971, the authors
concluded that:
"Rabbit eye and skin procedures current
ly recommended by the federal agencies
for use in the delineation of irritancy of
materials should not be recommended as
standard procedures in any new regula
tions. Without careful reeducation,
these tests result in unreliable results."
The FDA conducted a follow-up study and con
cluded that the data in the 1971 report was essentially
correct. However, the FDA authors placed a differ
ent interpretation on the results. They argued that
the 1971 study had made the mistake of using the
Draize test to attempt to discriminate between differ
ent grades of irritants. Instead, the Draize test should
only be used to distinguish an irritant from a non
irritant and not to determine the degree of irritancy.
Using this caveat, the FDA scientists argued that the
Draize test could be used to evaluate the safety of a
substance in a simple pass-fail manner. Even in this
pass-fail situation, there is still no guarantee that a
substance which is a non-irritant in a rabbit will be a
non-irritant in a human eye and vice versa.
Despite the clear problems associated with the
Draize test and disagreement among scientists, it is
still being recommended as a standard test for eye
irritants by federal agencies.

The HSUS bas sent detailed arguments to the gov
ernment agencies involved, outlining why the Draize
test should be dropped and asking them to immedi
ately fund research into alternatives. As part of the
arguments, The HSUS pointed out that there are
three interlocking elements which lead to the in
evitable conclusion that the Draize test can no longer
be justified as a routine test for eye irritancy.
(1) The test will cause suffering and, in some cases,
a great deal of suffering to the rabbits being used.
Many toxicological technicians have expressed strong
feelings against the test, especially in those instances
where the rabbits scream when the test substance is
introduced into the eye.
(2) The information produced by the test is crude
at best and totally unreliable at worst. Where routine
testing is carried out, a test should be highly repro
ducible, especially when many different laboratories
are involved.
(3) The prospects for developing an alternative to
the Draize test are very good. However, time and
money are required, and no government agency or
commercial organization has yet devoted sufficient
time, money, or energy to the task. The techniques

are available, but the will to select the best one and to
validate it has, so far, been lacking.

What are the Alternatives?
In April, 1978, a contract research organization in
England reported on the results of some preliminary
work to develop a cell culture alternative to the
Draize test. Three shampoos of known irritancy
(low, moderate, and high) were tested. In all cases,
the cell system distinguished between shampoos of
high and low irritancy. The cell test did not reliably
distinguish between the moderately irritant shampoo
and the other two. The organization stressed that the
results are preliminary and the discriminatory powers
of the test need to be improved. They concluded
there is "a basis for an in vitro system for the screen
ing of severe irritants as an alternative to the Draize
test." Partly as a result of this work and of consumer
pressure, several cosmetic companies in England
have collaborated to support further research by a
single scientist on tissue culture tests for screening
irritants.

The Results Aren't Pretty!

The above photographs show four grades of rabbit
eye reaction to irritants. The first picture on the left
shows a normal eye. The second picture shows an eye
with maximum marks (3) for redness. The third pieture demonstrates what is meant by the development
of opacity. This eye achieves maximum marks (4) for

opacity. The final picture shows an eye which
achieves maximum marks (4) for cbemosis (swelling
of conjunctivae due to fluid collection in cells and
between cells). As one might imagine, any substance
which produces a reaction this severe is also likely to
cause a lot of pain.

The Cosmetic Industry and the Draize Test

The cosmetic and toiletries industry is currently
estimated at a $10 billion per annum market. About
4,000 companies manufacture and sell cosmetics.
However, only ten companies control approximately
three-fifths of the total market with Avon, Bristol
Myers, Revlon, and Proctor & Gamble leading the
industry in 1977, followed by Colgate-Palmolive,
Gillette, and Chesebrough-Ponds, according to a
market survey by Frost & Sullivan.
Some companies do no animal testing and yet
market safe products. The reasons for this lack of
animal testing differ. For example, Yardley claims to
do no animal testing, but this is because their product
ines have been on the market for a long time and
they have developed no new products which would

require additional testing. If they were to develop
new products, they probably would test on animals.
Some companies do no animal testing because of
their ethical stand against the use of animals or
animal products. However, companies which take an
ethical stand against animal testing are tiny when
compared to the industry giants and their products
are difficult to obtain except in health food stores.
The cosmetic industry as a whole should be urged
to make a positive commitment to deal with the
problem of animal testing by developing and validat
ing adequate alternatives. There have been a number
of initiatives to pressure the industry into making a
positive commitment to "alternatives" but, so far,
without success. The most recent and probably most

detailed effort was launched by the Coalition to Stop
Draize Rabbit Blinding Tests. After a number of ef
forts to interest Revlon to seek alternatives, HSUS's
Dr. Rowan and Mr. Spira of the Coalition met with
the Revlon Vice-President of Public Affairs. As a
result of that meeting, the Coalition was invited to
put forward a proposal for Revlon's consideration.
The proposal pointed out the scientific and ethical
problems of the Draize test. It asked Revlon, as one
of the leaders of the cosmetic industry, to approach
the Cosmetic, Toiletry and Fragrance Association
with a proposal that the CTFA should organize a col
laborative effort by the industry to develop an alter
native to the Draize test which does not involve the
use of live animals. As part of the proposal, it was
suggested that Revlon should allocate one hundredth
of one percent of its gross annual sales to the project
as an indication of good faith.
Revlon referred the proposal to the CTFA's Com
mittee on Pharmacology and Toxicology for consid
eration by a subcommittee which had been estab
lished to review short-term testing procedures for the
industry. Part of Revlon's response to the Coalition's
proposal reads as follows: "Neither Revlon, nor any

other single company, can give any assurances as to
what action, if any, this committee, or any other
committee of the CTFA, may take on this matter, ex
cept to say that it will receive consideration. "Neither

the Coalition nor HSUS consider this to be an ade
quate response. If Revlon had committed funds to
the idea of developing an alternative prior to refer-

ring the proposal to the CTFA, it might have stood a
better chance of acceptance. Without Revlon's sup
port, the outcome looks bleak.

Humane Groups form
Coalition to Abolish
Draize Test

The creation of Henry Spira, a New York City
teacher, the Coalition is sponsored by The HSUS and
other national groups. Several HSUS staff members,
including Dr. Andrew Rowan of the Institute for the
Study of Animal Problems and HSUS President
John A. Hoyt, are working closely with Mr. Spira,
who is serving as coordinator. More than 300 local
animal welfare groups have added their support to
the Coalition in response to a national appeal.
A number of steps have already been taken by the
Coalition. These initiatives include letters to federal
agencies, an approach to the Cosmetic, Toiletry and
Fragrance Association, and a specific proposal to
Revlon to help with the development of an alterna
tive to the Draize test.
Unless the company gives some early indication
that it will actively support the development of an al
ternative to the Draize test, the Coalition is prepared
to consider other measures, including the possibility
of enlisting consumer buying power by requesting
concerned humanitarians to stop buying Revlon
products.

An old type of stock used for restraining rabbits for experimental purposes. One rabbit is struggling to free
itself.
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The Bureaucratic Maze and the Draize
There are several federal agencies which require
eye irritancy testing-either explicitly or implicitly.
These include the Consumer Product Safety Com
mission, the Food and Drug Administration, and the
Environmental Protection Agency. The chart out
lines their areas of responsibility and the enabling
legislation leading to Draize eye testing.

Both EPA and CPSC have based their eye irritan
cy test requirements on the Draize method in which
the albino rabbit must be used. With regard to cos
metics, the FDA has no authority to require test data
prior to marketing of a new product, but each new
product must either be "adequately substantiated for
safety" or bear a warning statement that "the safety
of this product has not been determined."
Chemicals
Covered

Agency

Enabling Legislation

Address

Consumer Product
Safety Commission
(CPSC)

Federal Hazardous
Substances Act

Associate Executive
Director
Hazardous Substances
Identification
and Analysis (CPSC)
Washington, D.C. 20207

Includes general
household products
and consumer items
consisting of mix
tures of chemicals
Pesticides

Environmental
Protection Agency
(EPA)

Federal Insecticide
Fungicide and
Rodenticide Act
(FIFRA)

Office of Pesticide
Programs
EPA
Washington, D.C. 20460

Environmental
Protection Agency
(EPA)

Toxic Substances
Control Act
(TOSCA)

Office of Toxic Substances Chemicals not
EPA
covered by other
Washington, D.C. 20460
three acts

Food and Drug
Administration
(FDA)

Federal Food,
Drug and Cos
metic Act

Division of Cosmetics
Technology
FDA, 200 C Street, S.W.
Washington, D.C. 20024

Includes cosmetics,
ophthalmic products
and other therapeutic
agents.

Ohio Court Rules on Draize Test
In January, 1974, the Food and Drug Ad
ministration (FDA) went to court against the
producers of Beacon Castile Shampoo with
Lanolin. A young girl using the shampoo had
suffered eye damage after some shampoo had
gotten into her eye. The Northern District
Court of Ohio ruled in favor of the company.
The court said FDA had: (a) failed to show
that the shampoo was any more hazardous
than similar products on the market, and (b)
failed to show that the results of tests on rabbit
eyes can be extrapolated to humans. The FDA
had determined that the shampoo was an irri
tant by means of the Draize test.

The court also ruled FDA had failed to show
that the full concentrate of shampoo might get
into the user's eye under normal conditions of
use and that the user would not. ordinarily
flush the shampoo out of the eye immediately.
In a memorandum dated Feburary 6, 1974,
the FDA legal counsel argued that the FDA
should, in the future, have sound evidence and
a consistent medical and scientific rationale for
charging potential injury to health. The impli
cations of this argument are that the Draize
test does not provide sound evidence for the
court; and, therefore, it is arguable whether
the test provides evidence to establish the safe
ty of a product.
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What You Can Do
v Buy cosmetics which have been on the market for
a long time. Usually, well-established or well-known
fragrances, lipsticks, powders, etc., which have been
marketed for some time have not been tested on
animals.
v Make an effort to find out if the products you
regularly use have been tested on animals. Ask sales
clerks, write to the companies, read the labels.
v Write to the Cosmetic, Toiletry and Fragrance
Association, 1133-ISth Street, N.W. Washington,

Support HSUS Efforts
To Stop the Use of
The Draize Test
It causes pain and it's unreliable, yet governme.n t
agencies and cosmetic companies are still using the
Draize test. Why? Because they haven't chosen to ex
plore potential alternative techniques. The economic
incentive to find a new test for eye irritancy is not
present. It's fairly inexpensive to use the rabbits.
Alternatives may cost less but the difference is not
enough to spur action.
Reason has not worked. Economic, social, and
political pressure are the tools we must employ to end
the use of this cruel test. The federal agencies and the
cosmetic companies must be convinced of our deter
mination to end the pain and suffering to defenseless
creatures.
Your support is urgently needed for a victory on
the Draize test.
Your individual action is important, but equally
important is the united action of the Draize Coalition
and The HSUS. Funds are needed to continue to
carry on personal contacts, letter writing campaigns,
and scholarly research required to make the research
community employ alternative testing methods.
Send your tax-deductible contribution to The
HSUS today. Join forces with The HSUS in this
essential movement to protect our fellow creatures.
Remember, just saying you like animals is not
enough!

D.C. 20005, stating your objection to the Draize test.
Ask that they orchestrate a collaborative effort by
the industry to develop alternatives. They may send
you a pamphlet entitled: "Animal Testing: What are
the Choices?" This pamphlet is directed to the whole
field of animal testing and not just the Draize test.
React to the pamphlet! Write back and explain the
results on the 1971 survey which revealed the unrelia
bility of the Draize test. Tell them about the Ohio
court case. Send copies of letters and replies to The
HSUS.
v Write to the Food and Drug Administration
stating your objection to the Draize test. Ask that
FDA begin the search for an alternative now!
v Write to the cosmetics companies themselves.
Urge them to support the search for alternatives. Ask
them to allocate one-hundredth of one percent of
gross annual sales to finding an alternative as sug
gested by the Coalition. Stress your objections to the
use of rabbits by them or companies they have con
tracted with for research. Remember, every letter is
valuable. Some companies will initiate action after
receiving very few letters.
v Use the elements of this Close-Up Report to write
a letter. to the editor of your local newspaper. Send
copies to HSUS.
v Write letters to the editors of magazines you read,
especially magazines which carry cosmetic advertis
ing. Your letter might be printed. Or, better yet, you
may give an editorial person an idea for a story.

Additional copies of this report are available upon request at 10¢ each.
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